Mauro Andreotti
Overview
Explore the profile of Mauro Andreotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
896
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baroncelli S, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
J Trop Pediatr
. 2025 Mar;
71(2).
PMID: 40064194
Serological studies in infants can provide valuable information on the degree of protection conferred by IgG maternal passive transfer during early life. If infant levels are inadequate, protection may be...
2.
Flego M, Andreotti M, Mauro F, Arasi M, Zamboni S, Michelini Z, et al.
Biomolecules
. 2025 Jan;
15(1).
PMID: 39858511
In chronic lymphocytic leukemia (CLL), natural killer (NK) cells show a dysfunctional phenotype that correlates with disease progression. Our aim was to restore NK cell functionality in CLL through a...
3.
Farina I, Andreotti M, Pastori C, Bona R, Galluzzo C, Amici R, et al.
Virus Res
. 2024 Dec;
350:199506.
PMID: 39638260
CCR5 is the main co-receptor for HIV-1 cell entry and it plays key roles in HIV-1 mucosal transmission. Natural anti-CCR5 antibodies were found in HIV-1-exposed seronegative and long-term non-progressor subjects,...
4.
Baroncelli S, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
BMJ Paediatr Open
. 2024 Sep;
8(1).
PMID: 39317654
In Malawi, tetanus toxoid vaccination (TTV) is recommended in pregnancy, but few studies have assessed the prevalence of infant seroprotection against tetanus. Anti-TT levels from 84 6-week-old infants, born in...
5.
Ferrantelli F, Manfredi F, Chiozzini C, Leone P, Pugliese K, Spada M, et al.
Vaccines (Basel)
. 2023 Sep;
11(9).
PMID: 37766110
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 enters the host by infecting nasal ciliated cells. Then, the virus can spread towards the oropharyngeal cavity and the pulmonary tissues. The antiviral adaptive...
6.
Baroncelli S, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
Trop Med Int Health
. 2023 Aug;
28(9):731-735.
PMID: 37533039
Measles vaccination is currently recommended at 9 months, since maternal antibodies are supposed to protect infants until that age. In this study of 6-month-old Malawian infants 98.3% (58/59) had non-protective...
7.
Baroncelli S, Galluzzo C, Orlando S, Pirillo M, Luhanga R, Mphwere R, et al.
Pathogens
. 2023 Jul;
12(7).
PMID: 37513785
Background: The evaluation of seroprotection rates against vaccine-preventable infectious diseases allows for the identification of risk populations. HIV-exposed infants, even if not infected with HIV, have higher morbidity and mortality...
8.
Floridia M, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
Nutrients
. 2023 Jul;
15(14).
PMID: 37513701
Breastfed Malawian infants from Human Immunodeficiency Virus (HIV)-uninfected and HIV-infected women who received antiretroviral therapy were followed until 12 months of age, allowing us to evaluate plasma levels of ferritin,...
9.
Giuliano M, Pirillo M, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
Acta Trop
. 2023 Jul;
246:106987.
PMID: 37454709
In sub-Saharan Africa the great majority of infants acquire Cytomegalovirus (CMV) infection within the first year of life. Maternal long-term antiretroviral therapy (ART) has been suggested to reduce the rate...
10.
Manfredi F, Chiozzini C, Ferrantelli F, Leone P, Pugliese K, Spada M, et al.
NPJ Vaccines
. 2023 Jun;
8(1):83.
PMID: 37268624
Induction of effective immunity in the lungs should be a requisite for any vaccine designed to control the severe pathogenic effects generated by respiratory infectious agents. We recently provided evidence...